Literature DB >> 32355486

Syringocystadenoma Papilliferum: A Case Report and Review of the Literature.

Khalid Al Hawsawi1, Amani Alharazi2, Abeer Ashary1, Asmaa Siddique1.   

Abstract

Syringocystadenoma papilliferum is a very rare, benign adnexal tumor that originates from the apocrine sweat glands. Herein, we report a 25-year-old male who presented with a 10-year history of an asymptomatic slowly growing skin lesion on his face. Skin examination revealed a solitary rounded 3 × 3 cm erythematous plaque with central crustation on the right side of his face. Punch skin biopsy was taken from the lesion. The epidermis showed downward papillomatous extensions. The dermis showed multiple epithelial sheets and dilated ducts that were lined by columnar cells. On the basis of the above clinicopathological findings, the diagnosis of syringocystadenoma papilliferum was made. The patient was reassured and referred to a surgeon for surgical excision of the lesion.
Copyright © 2019 by S. Karger AG, Basel.

Entities:  

Keywords:  Apocrine adenoma; Syringocystadenoma papilliferum

Year:  2019        PMID: 32355486      PMCID: PMC7184794          DOI: 10.1159/000497054

Source DB:  PubMed          Journal:  Case Rep Dermatol        ISSN: 1662-6567


Introduction

Syringocystadenoma papilliferum (SP) is a very rare, benign adnexal tumor that originates from the apocrine or eccrine sweat glands. However, in rare cases, SP may convert into a malignant lesion [1]. SP is common during childhood or early adulthood and occurs as asymptomatic slowly growing crusted reddish papule or plaque. SP is rarely pigmented. The most common location is the scalp and face. It rarely occurs on the nipple, breast, genitalia, eyelids, and extremities [1, 2, 3]. SP can be single or multiple. The cause of SP is not clear. One-third of SP arises in nevus sebaceous [1, 2]. BRAF V600E mutation or activating mutations in HRAS (or less often KRAS) have been reported in sporadic forms, whereas nevus sebaceous carries the same HRAS mutation as the underlying nevus [1].

Case Report

A 25-year-old male presented with a 10-year history of an asymptomatic slowly growing solitary skin lesion on his face. The lesion sometimes oozed fluid or became ulcerated or bled. He had been using several topical and systemic steroids, antibiotics, and antifungals for years but without improvement. Past medical history, family history, and review systems were unremarkable. Skin examination revealed a solitary rounded 3 × 3 cm fleshy plaque with central crustation on the right side of his face (Fig. 1). There was no lymphadenopathy. Punch skin biopsy was taken from the lesion. The epidermis showed downward papillomatous extensions. The dermis showed multiple epithelial sheets and dilated ducts that were lined by columnar cells (Fig. 2). On the basis of the above clinicopathological findings, the diagnosis of SP was made. The patient was reassured and referred to a surgeon for surgical excision of the lesion.
Fig. 1

Solitary rounded 3 × 3 cm erythematous plaque with central crustation on the right side of his face.

Fig. 2

Punch skin biopsy from the lesion. The epidermis shows downward papillomatous extensions. The dermis shows multiple epithelial sheets and dilated ducts that are lined by columnar cells.

Discussion

SP is a rare benign adnexal neoplasm that originates from either apocrine or eccrine sweat glands. The main differential diagnosis in our case includes basal cell carcinoma, cutaneous lymphoma, factitious dermatitis, and pyogenic granuloma. However, slowly growing fleshy plaque that has been growing for years and sometimes oozes fluid and sometimes bleeds is characteristic for SP. Syringocystadenocarcinoma papilliferum, which is the malignant counterpart of SP, should be ruled out when evaluating the histopathology of SP [4]. Basal cell carcinoma has been reported to be seen in 10% of patients with SP. So, a patient with SP should be evaluated for associated basal cell carcinoma. The treatment of choice of SP is surgical excision. However, recurrence is common [1, 2, 5]. Our case was treated by surgical excision, with no recurrence until the time of the report.

Statement of Ethics

The authors have no ethical conflicts to disclose. Written consent has been obtained from the patient.

Disclosure Statement

The authors have no conflicts of interest to declare.

Funding Sources

No sources of funding were used to assist in the preparation of the manuscript.

Author Contributions

Conception and design of the study: Khalid Al Hawsawi. Data collection: Amani Alharazi. Introduction and discussion: Amani Alharazi, Abeer Ashary, Asmaa Siddique. Drafting the manuscript: Amani Alharazi, Abeer Ashary, Asmaa Siddique. Revising the manuscript critically for important intellectual content: Khalid Al Hawsawi. Approval of the version of the manuscript to be published: Khalid Al Hawsawi.
  4 in total

1.  Syringocystadenoma papilliferum of the male nipple.

Authors:  Satomi Kasashima; Atsuhiro Kawashima; Takahiko Fujii
Journal:  J Cutan Pathol       Date:  2016-05-18       Impact factor: 1.587

2.  A Histological Snapshot of Hypothetical Multistep Progression From Nevus Sebaceus to Invasive Syringocystadenocarcinoma Papilliferum.

Authors:  Vishwas Parekh; Cesar E Guerrero; Charles F Knapp; Craig A Elmets; Kristopher M McKay
Journal:  Am J Dermatopathol       Date:  2016-01       Impact factor: 1.533

3.  An 8-year-old girl with a papule on her cheek.

Authors:  Natalia M Fontecilla; Rhett A Kent; Kalyani S Marathe
Journal:  Pediatr Dermatol       Date:  2018-07       Impact factor: 1.588

4.  Syringocystadenocarcinoma papilliferum: case report and immunohistochemical comparison with its benign counterpart.

Authors:  A Ishida-Yamamoto; K Sato; T Wada; H Takahashi; H Iizuka
Journal:  J Am Acad Dermatol       Date:  2001-11       Impact factor: 11.527

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.